Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms

被引:0
|
作者
Winter, Susann [1 ]
Schneider, Marie [2 ]
Oelschlaegel, Uta [1 ]
Maggioni, Giulia [3 ,4 ]
Riva, Elena [3 ,4 ]
Raddi, Marco Gabriele [5 ]
Bencini, Sara [6 ]
Peruzzi, Benedetta [6 ]
Choy, Desmond [3 ]
Antunes Dos Reis, Rita [3 ]
Guese, Esther [7 ,8 ]
Lischer, Christopher [7 ,8 ]
Vera, Julio [7 ,8 ]
Timms, Jessica A. [3 ]
Sompairac, Nicolas [3 ]
Sockel, Katja [1 ]
Poloni, Antonella [9 ]
Tunger, Antje [10 ,11 ,12 ,13 ,14 ,15 ]
Della Porta, Matteo Giovanni [4 ,16 ]
Santini, Valeria [5 ]
Schmitz, Marc [10 ,11 ,12 ,13 ,14 ,15 ,17 ,18 ]
Platzbecker, Uwe [2 ,17 ,18 ,19 ]
Kordasti, Shahram [3 ,9 ,20 ]
机构
[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Fac Med Carl Gustav Carus, Dept Internal Med 1, Dresden, Germany
[2] Univ Leipzig Med Ctr, Dept Hematol Cellular Therapy & Hemostaseol & Inf, Leipzig, Germany
[3] Kings Coll London, Comprehens Canc Ctr, Sch Canc & Pharmaceut Sci, London, England
[4] IRCCS Humanitas Res Hosp, Milan, Italy
[5] Univ Florence, AOU Careggi Dept Expt & Clin Med, MDS Unit, Hematol, Florence, Italy
[6] AOU Careggi, Flow Cytometry Diagnost Ctr & Immunotherapy CDCI, Florence, Italy
[7] Friedrich Alexander Univ Erlangen Nurnberg, Lab Syst Tumor Immunol, Univ klinikum Erlangen, Erlangen, Germany
[8] Comprehens Canc Ctr Erlangen EMN, Deutsch Zent Immuntherapie, Erlangen, Germany
[9] Univ Politecn Marche, Dept Clin & Mol Sci, Ancona, Italy
[10] Tech Univ Dresden, Inst Immunol, Fac Med Carl Gustav Carus, Dresden, Germany
[11] Natl Ctr Tumor Dis NCT, Dresden, Germany
[12] Tech Univ Dresden, German Canc Res Ctr DKFZ, Dresden, Germany
[13] Tech Univ Dresden, Fac Med, Dresden, Germany
[14] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany
[15] Helmholtz Zentrum Dresden Rossendorf HZDR, Dresden, Germany
[16] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[17] German Canc Consortium DKTK, Partner Site Dresden, Heidelberg, Germany
[18] German Canc Res Ctr, Heidelberg, Germany
[19] German MDS Study Grp D MDS, Leipzig, Germany
[20] Guys Hosp, Haematol Dept, London, England
关键词
IMMUNOSUPPRESSIVE THERAPY; MDS;
D O I
10.1038/s41375-024-02249-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1427 / 1431
页数:5
相关论文
共 35 条
  • [1] Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1
    Trsova, Iva
    Hrustincova, Andrea
    Krejcik, Zdenek
    Kundrat, David
    Holoubek, Ales
    Staflova, Karolina
    Janstova, Lucie
    Vanikova, Sarka
    Szikszai, Katarina
    Klema, Jiri
    Rysavy, Petr
    Belickova, Monika
    Kaisrlikova, Monika
    Vesela, Jitka
    Cermak, Jaroslav
    Jonasova, Anna
    Dostal, Jiri
    Fric, Jan
    Musil, Jan
    Merkerova, Michaela Dostalova
    MOLECULAR ONCOLOGY, 2023, 17 (12) : 2565 - 2583
  • [2] Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
    Malcovati, Luca
    Papaemmanuil, Elli
    Bowen, David T.
    Boultwood, Jacqueline
    Della Porta, Matteo G.
    Pascutto, Cristiana
    Travaglino, Erica
    Groves, Michael J.
    Godfrey, Anna L.
    Ambaglio, Ilaria
    Galli, Anna
    Da Via, Matteo C.
    Conte, Simona
    Tauro, Sudhir
    Keenan, Norene
    Hyslop, Ann
    Hinton, Jonathan
    Mudie, Laura J.
    Wainscoat, James S.
    Futreal, P. Andrew
    Stratton, Michael R.
    Campbell, Peter J.
    Hellstrom-Lindberg, Eva
    Cazzola, Mario
    BLOOD, 2011, 118 (24) : 6239 - 6246
  • [3] SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients With Lower-Risk Myelodysplastic Syndrome
    Falantes, Jose F.
    Marquez-Malaver, Francisco J.
    Carrillo, Estrella
    Garcia Culebras, Marta
    Morales, Rosario
    Prats, Concepcion
    Vargas, Maria T.
    Caballero, Teresa
    Rodriguez-Arboli, Eduardo
    Espigado, Ildefonso
    Perez-Simon, Jose Antonio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (12): : E1059 - E1066
  • [4] SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients with Lower-Risk Myelodysplastic Syndrome
    Falantes, Jose F.
    Marquez-Malaver, Francisco J.
    Carrillo-Cruz, Estrella
    Morales-Camacho, Rosario M.
    Prats-Martin, Concepcion
    Caballero, Teresa
    Rodriguez Arboli, Eduardo
    Espigado, Ildefonso
    Perez-Simon, Jose A.
    BLOOD, 2022, 140 : 6920 - 6922
  • [5] Different Mutations in SF3B1 Gene Have Specific Transcriptomic Characteristics in Myelodysplastic Neoplasms
    Trsova, Paneliva
    Hrustincova, Andrea
    Belickova, Monika
    Kaisrlikova, Monika
    Lenertova, Zuzana
    Kundrat, David
    Krejcik, Zdenek
    Vesela, Jitka
    Cermak, Jaroslav
    Jonasova, Anna
    Merkerova, Michaela Dostalova
    BLOOD, 2023, 142
  • [6] Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma
    Harbour, J. William
    Roberson, Elisha D. O.
    Anbunathan, Hima
    Onken, Michael D.
    Worley, Lori A.
    Bowcock, Anne M.
    NATURE GENETICS, 2013, 45 (02) : 133 - 135
  • [7] Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma
    J William Harbour
    Elisha D O Roberson
    Hima Anbunathan
    Michael D Onken
    Lori A Worley
    Anne M Bowcock
    Nature Genetics, 2013, 45 : 133 - 135
  • [8] Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes
    Patel, Jay L.
    Abedi, Mehrdad
    Cogle, Christopher R.
    Erba, Harry P.
    Foucar, Kathryn
    Garcia-Manero, Guillermo
    Grinblatt, David L.
    Komrokji, Rami S.
    Kurtin, Sandra E.
    Maciejewski, Jaroslaw P.
    Pollyea, Daniel A.
    Revicki, Dennis A.
    Roboz, Gail J.
    Savona, Michael R.
    Scott, Bart L.
    Sekeres, Mikkael A.
    Steensma, David P.
    Thompson, Michael A.
    Flick, Elizabeth Dawn
    Kiselev, Pavel
    Louis, Chrystal U.
    Nifenecker, Melissa
    Swern, Arlene S.
    George, Tracy, I
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (03) : 426 - 432
  • [9] Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization
    Liu, Zhaoqi
    Yoshimi, Akihide
    Wang, Jiguang
    Cho, Hana
    Lee, Stanley Chun-Wei
    Ki, Michelle
    Bitner, Lillian
    Chu, Timothy
    Shah, Harshal
    Liu, Bo
    Mato, Anthony R.
    Ruvolo, Peter
    Fabbri, Giulia
    Pasqualucci, Laura
    Abdel-Wahab, Omar
    Rabadan, Raul
    CANCER DISCOVERY, 2020, 10 (06) : 806 - 821
  • [10] Mutations in the RNA Splicing Factor SF3B1 Promote Transformation through MYC Stabilization
    Yoshimi, Akihide
    Liu, Zhaoqi
    Wang Jiguang
    Cho, Hana
    Lee, Stanley C.
    Ki, Michelle
    Bitner, Lillian E.
    Chu, Timothy
    Mato, Anthony R.
    Ruvolo, Peter P.
    Fabbri, Giulia
    Pasqualucci, Laura
    Rabadan, Raul
    Abdel-Wahab, Omar I.
    BLOOD, 2018, 132